These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17525188)

  • 41. Occlusion therapy of Japanese children with anisometropic amblyopia without strabismus.
    Noda S; Hayasaka S; Setogawa T
    Ann Ophthalmol; 1993 Apr; 25(4):145-7. PubMed ID: 8484657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Amblyopia Using Personalized Dosing Strategies: Statistical Modelling and Clinical Implementation.
    Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR;
    Strabismus; 2016 Dec; 24(4):161-168. PubMed ID: 27929726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time course and predictors of amblyopia improvement with 2 hours of daily patching.
    Wallace DK; Lazar EL; Crouch ER; Hoover DL; Kraker RT; Tamkins SM;
    JAMA Ophthalmol; 2015 May; 133(5):606-9. PubMed ID: 25695355
    [No Abstract]   [Full Text] [Related]  

  • 44. Contact lenses in the management of high anisometropic amblyopia.
    Roberts CJ; Adams GG
    Eye (Lond); 2002 Sep; 16(5):577-9. PubMed ID: 12194072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electronic monitoring of occlusion treatment for amblyopia in patients aged 7 to 16 years.
    Fronius M; Bachert I; Lüchtenberg M
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1401-8. PubMed ID: 19415317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association Between Adherence to Glasses Wearing During Amblyopia Treatment and Improvement in Visual Acuity.
    Maconachie GD; Farooq S; Bush G; Kempton J; Proudlock FA; Gottlob I
    JAMA Ophthalmol; 2016 Dec; 134(12):1347-1353. PubMed ID: 27737444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors affecting the stability of visual function following cessation of occlusion therapy for amblyopia.
    Tacagni DJ; Stewart CE; Moseley MJ; Fielder AR
    Graefes Arch Clin Exp Ophthalmol; 2007 Jun; 245(6):811-6. PubMed ID: 17047980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treating amblyopia with liquid crystal glasses: a pilot study.
    Spierer A; Raz J; Benezra O; Herzog R; Cohen E; Karshai I; Benezra D
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3395-8. PubMed ID: 20164454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful occlusion therapy for amblyopia in 11- to 15-year-old children.
    Mohan K; Saroha V; Sharma A
    J Pediatr Ophthalmol Strabismus; 2004; 41(2):89-95. PubMed ID: 15089063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Results of treatment for anisometropic amblyopia with and with squint].
    Nowakowska O; Broniarczyk-Loba A; Goetz J
    Klin Oczna; 1994; 96(6-7):193-6. PubMed ID: 7897971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of telescopic magnification in the treatment of amblyopia: a pilot study.
    Wu J; Nazemi F; Schofield J; Mirabella G; Wong AM
    Arch Ophthalmol; 2010 Mar; 128(3):297-302. PubMed ID: 20212198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intense versus standard regimens of intermittent occlusion therapy for unilateral moderate amblyopia in children: study protocol for a randomized controlled trial.
    Wang J; Malik A; Jin J; Pang Y; Yin K; Allen M; Grigorian A; Scombordi B; Bailey J; Aljohani S; Funari K; Shoge R; Meiyeppen S; Myung J; Soni A; Neely DE
    Trials; 2020 Apr; 21(1):361. PubMed ID: 32345348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long term vision outcomes of conventional treatment of strabismic and anisometropic functional amblyopia.
    Garoufalis P; Georgievski Z; Koklanis K
    Binocul Vis Strabismus Q; 2007; 22(1):49-56. PubMed ID: 17417966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of amblyopia.
    Holmes JM; Repka MX; Kraker RT; Clarke MP
    Strabismus; 2006 Mar; 14(1):37-42. PubMed ID: 16513568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opaque contact lens treatment for older children with amblyopia.
    Anderson JE; Brown SM; Mathews TA; Mathews SM
    Eye Contact Lens; 2006 Mar; 32(2):84-7. PubMed ID: 16538129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Occlusion therapy for strabismic amblyopia.
    Elder MJ
    Aust N Z J Ophthalmol; 1994 Aug; 22(3):187-91. PubMed ID: 7818877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visual acuity deficits in the fellow eyes of children with unilateral amblyopia.
    Varadharajan S; Hussaindeen JR
    J AAPOS; 2012 Feb; 16(1):41-5. PubMed ID: 22370664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of visual acuity in a historical cohort of 137 patients treated for amblyopia by occlusion 30-35 years ago].
    Simonsz-Tóth B; Loudon SE; van Kempen-du Saar H; van de Graaf ES; Groenewoud JH; Simonsz HJ
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):40-6. PubMed ID: 17260318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visual prognosis of amblyopia associated with myelinated retinal nerve fibers.
    Kee C; Hwang JM
    Am J Ophthalmol; 2005 Feb; 139(2):259-65. PubMed ID: 15733986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. When is it safe to stop patching?
    Oster JG; Simon JW; Jenkins P
    Br J Ophthalmol; 1990 Dec; 74(12):709-11. PubMed ID: 2275932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.